In focus · trending topic

Apellis

16 stories · following the connections

Apellis Pharmaceuticals Reports First Quarter 2018 Business Update and Financial Results

By Nasdaq OMXApr 30, 2018, 8:00 PM UTC

Apellis Pharmaceuticals Announces Closing of Offering of Common Stock

By Nasdaq OMXApr 23, 2018, 10:21 PM UTC

Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock

By Nasdaq OMXApr 19, 2018, 1:26 AM UTC

Apellis Pharmaceuticals Announces Proposed Offering of Common Stock

By Nasdaq OMXApr 16, 2018, 9:12 PM UTC

Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab

By Nasdaq OMXApr 16, 2018, 1:23 PM UTC

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXMar 19, 2018, 8:30 PM UTC

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

By Nasdaq OMXFeb 23, 2018, 12:00 PM UTC

Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

By Nasdaq OMXFeb 22, 2018, 1:44 PM UTC